Cellebrite DI Ltd. (NASDAQ:CLBTW – Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 5,600 shares, a decrease of 11.1% from the March 15th total of 6,300 shares. Based on an average daily trading volume, of 62,100 shares, the short-interest ratio is currently 0.1 days.
Cellebrite DI Trading Down 2.0 %
Cellebrite DI stock traded down $0.04 during mid-day trading on Friday, hitting $1.97. The company’s stock had a trading volume of 17,138 shares, compared to its average volume of 65,904. Cellebrite DI has a 1 year low of $0.71 and a 1 year high of $2.94. The stock’s fifty day moving average is $2.27 and its two-hundred day moving average is $1.62.
Institutional Trading of Cellebrite DI
A hedge fund recently bought a new stake in Cellebrite DI stock. JPMorgan Chase & Co. purchased a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBTW – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 218,237 shares of the company’s stock, valued at approximately $268,000.
About Cellebrite DI
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.
See Also
- Five stocks we like better than Cellebrite DI
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 5 Trends You Need to Know This Quarter
- Best Stocks Under $10.00
- MarketBeat Week in Review – 4/8 – 4/12
- Airline Stocks – Top Airline Stocks to Buy Now
- You Can Follow BlackRock’s Market View for Your Money
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.